CRISPR-Cas9镍酶介导的基因编辑治疗亨廷顿氏病

{"title":"CRISPR-Cas9镍酶介导的基因编辑治疗亨廷顿氏病","authors":"Alvaro Murillo, M. Larin, Emma L. Randall, Alysha S. Taylor, M. Lelos, Vincent Dion","doi":"10.1136/jnnp-2022-ehdn.231","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":444837,"journal":{"name":"I: Experimental therapeutics – preclinical","volume":"86 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"I05 CRISPR-Cas9 nickase-mediated gene editing to treat Huntington’s disease\",\"authors\":\"Alvaro Murillo, M. Larin, Emma L. Randall, Alysha S. Taylor, M. Lelos, Vincent Dion\",\"doi\":\"10.1136/jnnp-2022-ehdn.231\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":444837,\"journal\":{\"name\":\"I: Experimental therapeutics – preclinical\",\"volume\":\"86 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"I: Experimental therapeutics – preclinical\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jnnp-2022-ehdn.231\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"I: Experimental therapeutics – preclinical","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jnnp-2022-ehdn.231","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}